Development and Validation of a Brief Digital Cognitive Screening Tool for HIV-associated Neurocognitive Disorder in Lima, Peru
This study developed and validated a brief, 14-minute digital cognitive screening battery comprising four tests (Birdwatch, Match, Set Shifting, and Rapid Naming) that demonstrates moderate accuracy for screening HIV-associated neurocognitive disorder among literate, Spanish-speaking adults in urban Lima, Peru, though further research is needed to refine its clinical application for diverse populations and lower literacy levels.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people living with HIV, modern medicine has turned a once-fatal diagnosis into a manageable chronic condition. With effective treatment, the virus can be suppressed to undetectable levels, allowing individuals to live long, healthy lives. Yet, even when the virus is under control, a silent complication can persist: HIV-associated neurocognitive disorder. This condition involves subtle but significant changes in thinking, memory, and the ability to process information. It is not a single disease but a collection of symptoms that can make daily tasks difficult, affecting a person's ability to work, manage finances, or maintain relationships. In many parts of the world, particularly in low-resource settings, identifying these changes is incredibly difficult. The standard way to diagnose such issues requires hours of testing by highly specialized doctors, a luxury that most clinics simply cannot afford. Without a reliable way to screen for these problems, many people slip through the cracks, their cognitive struggles going unnoticed and untreated.
In Lima, Peru, a team of researchers set out to solve this specific problem. They wanted to create a quick, digital way to check for these thinking problems that could be used in busy clinics without needing a specialist on hand. The team recruited hundreds of adults, some living with HIV and some without, to test a new approach. They used a tablet-based system that presents a series of short, interactive games designed to measure different parts of the brain's performance. These games ask users to match pictures, remember sequences, switch between tasks, and name objects quickly. The researchers first tested eleven different games to see which ones were best at spotting the specific type of thinking trouble common in people with HIV. They found that a combination of just four games worked best. This short battery, which takes about fourteen minutes to complete, was then tested on a new group of people to see if it could accurately distinguish between those with cognitive issues and those without.
The results showed that this brief digital tool holds real promise. When the researchers compared the results of the four-game tablet test against the results of the long, traditional paper-and-pencil tests used by specialists, the digital tool performed well. It correctly identified about 82 percent of the people who had the cognitive disorder, while correctly identifying about 71 percent of those who did not. This level of accuracy suggests the tool could serve as a useful first step in a clinic, flagging patients who need more comprehensive care. The study also established new, local standards for how these tests should be scored, taking into account the age and education levels of the people in Peru. This is a crucial detail, because tests developed in other countries often give misleading results when used elsewhere, sometimes labeling healthy people as impaired simply because they have different life experiences or schooling.
However, the researchers are careful to note that this tool is not a final diagnosis. A positive result on the tablet does not mean a person definitely has the disorder; it simply means they should be referred to a specialist for a deeper look. The study was conducted in an urban setting with people who had completed at least some primary school, so the results cannot yet be assumed to work for everyone, particularly those in rural areas or with very low literacy. The team emphasizes that while the tool is a significant step forward, it is not a magic bullet that solves the problem overnight. It is a practical, scalable method that fits into the reality of modern healthcare in Peru, offering a way to catch thinking problems early so that people can get the support they need. By proving that a short, digital screen can work in this specific context, the study opens the door for wider implementation, potentially changing how HIV care is delivered in Peru and beyond.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.